|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G16H 50/20 | (2018.01) |
| G16H 50/20 | (2018.01) | ||
| G16B 20/00 | (2019.01) | ||
| G16B 20/00 | (2019.02) | ||
| G16B 20/30 | (2019.01) | ||
| A61K 35/17 | (2013.01) | ||
| A61K 35/17 | (2015.01) | ||
| G16H 20/10 | (2018.01) | ||
| A61K 39/39 | (2006.01) | ||
| G16H 20/40 | (2018.01) |
| (11) | Number of the document | 3921851 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20753061.9 |
| Date of filing the European patent application | 2020-02-06 | |
| (97) | Date of publication of the European application | 2021-12-15 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/017055 |
| Date | 2020-02-06 |
| (87) | Number | WO 2020/163628 |
| Date | 2020-08-13 |
| (30) | Number | Date | Country code |
| 201962802135 P | 2019-02-06 | US |
| (72) |
DAVIS, Melissa, B. , US
|
| (73) |
Cornell University ,
Center for Technology Licensing
395 Pine Tree Road, Suite 310, Ithaca, NY 14850,
US
|
| (54) | DARC EXPRESSION AS PROGNOSTICATOR OF IMMUNOTHERAPY OUTCOMES |
| DARC EXPRESSION AS PROGNOSTICATOR OF IMMUNOTHERAPY OUTCOMES |